Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: correlation of dynamic susceptibility contrast-enhanced echoplanar imaging and hepatic angiography

被引:16
|
作者
Tsui, EYK [1 ]
Chan, JHM
Cheung, YK
Cheung, CC
Tsui, WC
Szeto, ML
Lau, KW
Yuen, MK
Lulin, SH
机构
[1] Tuen Mun Hosp, Dept Diagnost Radiol, Hong Kong, Hong Kong, Peoples R China
[2] Tuen Mun Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[3] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
hepatocellular carcinoma; chemoembolization; tumor perfusion; hepatic blood volume; DSC-MRI;
D O I
10.1016/S0899-7071(00)00204-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The objective of this study was to evaluate the therapeutic effectiveness of transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) with dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI). Seventeen patients with histopathologically proven HCC were included in this study. All patients underwent MR examinations with conventional T1- and T2-weighted images, gadolinium- enhanced images, and DSC-MRI before TACE treatment. Hepatic blood volume (HBV) maps were reconstructed from the time-intensity curves. The same MRI sequences and techniques were repeated 24 h and 6 weeks after TACE. Serial changes in tumor perfusion on HBV maps were correlated with vascularity in hepatic angiography. All tumors were hypointense on T1- weighted images and hyperintense on T2-weighted images. Heterogeneous enhancement was observed in all tumors before and immediately after TACE. Hyperperfusion was noted in most of the tumors on HBV map before TACE and moderate to marked hypoperfusion following TACE. The degree of tumor perfusion on HBV map correlated well with the vascularity in angiography, In conclusion, the noninvasive nature of DSC-MRI is useful to evaluate the effectiveness of TACE. Invasive procedures, such as angiography, are seldom necessary. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 50 条
  • [1] Detection of hepatic tumor perfusion following transcatheter arterial chemoembolization with dynamic susceptibility contrast-enhanced echoplanar imaging
    Chan, JHM
    Tsui, EYK
    Luk, SH
    Yuen, MK
    Cheung, YK
    Wong, KPC
    CLINICAL IMAGING, 1999, 23 (03) : 190 - 194
  • [2] Hepatocellular carcinoma treated with transarterial chemoembolization: Evaluation with parametric contrast-enhanced ultrasonography
    Moschouris, Hippocrates
    Malagari, Katerina
    Marinis, Athanasios
    Kornezos, Ioannis
    Stamatiou, Konstantinos
    Nikas, Georgios
    Papadaki, Marina Georgiou
    Gkoutzios, Panagiotis
    WORLD JOURNAL OF RADIOLOGY, 2012, 4 (08): : 379 - 386
  • [3] Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization
    Oezdemir, Ipek
    Shaw, Collette
    Eisenbrey, John R.
    Hoyt, Kenneth
    2019 IEEE 16TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2019), 2019, : 1737 - 1740
  • [4] Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: Evaluation with contrast-enhanced power Doppler sonography and contrast-enhanced harmonic imaging
    Esteban, JM
    Gil, J
    ACADEMIC RADIOLOGY, 2002, 9 : S382 - S383
  • [5] Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma
    Zhao, Ying
    Wang, Nan
    Wu, Jingjun
    Zhang, Qinhe
    Lin, Tao
    Yao, Yu
    Chen, Zhebin
    Wang, Man
    Sheng, Liuji
    Liu, Jinghong
    Song, Qingwei
    Wang, Feng
    An, Xiangbo
    Guo, Yan
    Li, Xin
    Wu, Tingfan
    Liu, Ai Lian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
    Park, Kil Hyo
    Kwon, Soon Ha
    Lee, Yong Sub
    Jeong, Soung Won
    Jang, Jae Young
    Lee, Sae Hwan
    Kim, Sang Gyune
    Cha, Sang-Woo
    Kim, Young Seok
    Cho, Young Deok
    Kim, Hong Soo
    Kim, Boo Sung
    Kim, Yong Jae
    CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (02) : 158 - 164
  • [7] Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma
    Saake, Marc
    Seuss, Hannes
    Hammon, Matthias
    Ellmann, Stephan
    May, Matthias
    Uder, Michael
    Schmid, Axel
    ACTA RADIOLOGICA, 2020, 61 (02) : 148 - 155
  • [8] mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization
    Moschouris, Hippocrates
    Malagari, Katerina
    Papadaki, Marina G.
    Kornezos, Ioannis
    Stamatiou, Konstantinos
    Anagnostopoulos, Antonios
    Chatzimichael, Katerina
    Kelekis, Nikolaos
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2014, 20 (02) : 136 - 142
  • [9] Evaluation of the viability of hepatocellular carcinoma in the caudate lobe using contrast-enhanced endoscopic ultrasonography after transarterial chemoembolization
    Nakaji, So
    Hirata, Nobuto
    ENDOSCOPIC ULTRASOUND, 2016, 5 (06) : 390 - 392
  • [10] Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound
    Shiozawa, Kazue
    Matsui, Takashi
    Murakami, Takahiro
    Watanabe, Manabu
    Maetani, Iruru
    DIAGNOSTICS, 2021, 11 (02)